- Home
- NUTX vs PRTA Comparison
NUTX vs PRTA Comparison
Compare NUTX & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUTX
- PRTA
- Stock Information
- Founded
- NUTX 2011
- PRTA 2012
- Country
- NUTX United States
- PRTA Ireland
- Employees
- NUTX N/A
- PRTA N/A
- Industry
- NUTX Retail: Computer Software & Peripheral Equipment
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- NUTX Technology
- PRTA Health Care
- Exchange
- NUTX Nasdaq
- PRTA Nasdaq
- Market Cap
- NUTX 967.1M
- PRTA 809.8M
- IPO Year
- NUTX N/A
- PRTA N/A
- Fundamental
- Price
- NUTX $118.81
- PRTA $5.98
- Analyst Decision
- NUTX Strong Buy
- PRTA Buy
- Analyst Count
- NUTX 2
- PRTA 9
- Target Price
- NUTX $262.50
- PRTA $27.67
- AVG Volume (30 Days)
- NUTX 144.8K
- PRTA 2.2M
- Earning Date
- NUTX 08-07-2025
- PRTA 08-07-2025
- Dividend Yield
- NUTX N/A
- PRTA N/A
- EPS Growth
- NUTX N/A
- PRTA N/A
- EPS
- NUTX 12.01
- PRTA N/A
- Revenue
- NUTX $624,284,633.00
- PRTA $137,935,000.00
- Revenue This Year
- NUTX $65.82
- PRTA N/A
- Revenue Next Year
- NUTX $4.98
- PRTA $30.93
- P/E Ratio
- NUTX $9.72
- PRTA N/A
- Revenue Growth
- NUTX 141.25
- PRTA 54.55
- 52 Week Low
- NUTX $4.16
- PRTA $4.32
- 52 Week High
- NUTX $184.28
- PRTA $25.42
- Technical
- Relative Strength Index (RSI)
- NUTX 39.00
- PRTA 46.16
- Support Level
- NUTX $117.20
- PRTA $4.95
- Resistance Level
- NUTX $136.81
- PRTA $6.00
- Average True Range (ATR)
- NUTX 12.17
- PRTA 0.32
- MACD
- NUTX -3.96
- PRTA 0.25
- Stochastic Oscillator
- NUTX 9.03
- PRTA 88.59
About NUTX Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).